Notice: TimeXNet Web will be temporarily affected due to Human Genome Center server maintenance until February 21 (Wednesday) 09:00 JST.
Job Name:
Phosphoproteome of mouse WT BMDCs stimulated with LPS
Current Gene List:
Background List:
Submitted Network
Note: Only the top 1000 records are shown here
Category | Term | Genes | Count | % | P-value | Benjamini |
---|---|---|---|---|---|---|
KEGG_PATHWAY | mmu05161:Hepatitis B | 73 | 8.8 | 1.6e-36 | 3.6e-34 | |
KEGG_PATHWAY | mmu04380:Osteoclast differentiation | 67 | 8.0 | 5.1e-36 | 5.7e-34 | |
KEGG_PATHWAY | mmu04668:TNF signaling pathway | 65 | 7.8 | 2.3e-35 | 1.7e-33 | |
KEGG_PATHWAY | mmu05169:Epstein-Barr virus infection | 83 | 10.0 | 1.8e-33 | 1.0e-31 | |
KEGG_PATHWAY | mmu05164:Influenza A | 74 | 8.9 | 7.3e-33 | 3.3e-31 | |
KEGG_PATHWAY | mmu04010:MAPK signaling pathway | 95 | 11.4 | 1.8e-32 | 6.7e-31 | |
KEGG_PATHWAY | mmu04620:Toll-like receptor signaling pathway | 57 | 6.8 | 3.2e-30 | 1.0e-28 | |
KEGG_PATHWAY | mmu04660:T cell receptor signaling pathway | 59 | 7.1 | 2.3e-29 | 6.4e-28 | |
KEGG_PATHWAY | mmu04722:Neurotrophin signaling pathway | 61 | 7.3 | 2.4e-28 | 5.8e-27 | |
KEGG_PATHWAY | mmu05145:Toxoplasmosis | 55 | 6.6 | 1.6e-26 | 3.5e-25 | |
KEGG_PATHWAY | mmu05210:Colorectal cancer | 43 | 5.2 | 1.9e-26 | 3.8e-25 | |
KEGG_PATHWAY | mmu05162:Measles | 62 | 7.4 | 5.2e-26 | 9.7e-25 | |
KEGG_PATHWAY | mmu05142:Chagas disease (American trypanosomiasis) | 55 | 6.6 | 3.3e-25 | 5.7e-24 | |
KEGG_PATHWAY | mmu04662:B cell receptor signaling pathway | 43 | 5.2 | 6.0e-25 | 9.6e-24 | |
KEGG_PATHWAY | mmu04664:Fc epsilon RI signaling pathway | 43 | 5.2 | 1.8e-24 | 2.6e-23 | |
KEGG_PATHWAY | mmu05212:Pancreatic cancer | 42 | 5.0 | 3.5e-24 | 4.9e-23 | |
KEGG_PATHWAY | mmu04064:NF-kappa B signaling pathway | 48 | 5.8 | 5.2e-23 | 6.8e-22 | |
KEGG_PATHWAY | mmu05215:Prostate cancer | 46 | 5.5 | 1.2e-22 | 1.4e-21 | |
KEGG_PATHWAY | mmu05220:Chronic myeloid leukemia | 42 | 5.0 | 1.2e-21 | 1.4e-20 | |
KEGG_PATHWAY | mmu04370:VEGF signaling pathway | 38 | 4.6 | 3.6e-21 | 4.0e-20 | |
KEGG_PATHWAY | mmu05200:Pathways in cancer | 106 | 12.7 | 1.1e-20 | 1.2e-19 | |
KEGG_PATHWAY | mmu05160:Hepatitis C | 55 | 6.6 | 4.2e-20 | 4.3e-19 | |
KEGG_PATHWAY | mmu04210:Apoptosis | 38 | 4.6 | 6.2e-20 | 6.0e-19 | |
KEGG_PATHWAY | mmu05203:Viral carcinogenesis | 67 | 8.0 | 8.9e-20 | 8.2e-19 | |
KEGG_PATHWAY | mmu05213:Endometrial cancer | 33 | 4.0 | 3.2e-19 | 2.8e-18 | |
KEGG_PATHWAY | mmu04012:ErbB signaling pathway | 44 | 5.3 | 4.6e-19 | 3.9e-18 | |
KEGG_PATHWAY | mmu05221:Acute myeloid leukemia | 33 | 4.0 | 9.1e-19 | 7.5e-18 | |
KEGG_PATHWAY | mmu05205:Proteoglycans in cancer | 70 | 8.4 | 1.0e-18 | 8.2e-18 | |
KEGG_PATHWAY | mmu04510:Focal adhesion | 66 | 7.9 | 2.1e-18 | 1.6e-17 | |
KEGG_PATHWAY | mmu05133:Pertussis | 38 | 4.6 | 3.9e-18 | 2.9e-17 | |
KEGG_PATHWAY | mmu04650:Natural killer cell mediated cytotoxicity | 44 | 5.3 | 1.9e-17 | 1.3e-16 | |
KEGG_PATHWAY | mmu05140:Leishmaniasis | 32 | 3.8 | 3.5e-17 | 2.4e-16 | |
KEGG_PATHWAY | mmu05214:Glioma | 34 | 4.1 | 2.1e-16 | 1.6e-15 | |
KEGG_PATHWAY | mmu04917:Prolactin signaling pathway | 37 | 4.4 | 3.1e-16 | 2.2e-15 | |
KEGG_PATHWAY | mmu05166:HTLV-I infection | 74 | 8.9 | 3.6e-16 | 2.1e-15 | |
KEGG_PATHWAY | mmu05168:Herpes simplex infection | 54 | 6.5 | 6.8e-16 | 4.1e-15 | |
KEGG_PATHWAY | mmu04071:Sphingolipid signaling pathway | 45 | 5.4 | 6.9e-16 | 4.0e-15 | |
KEGG_PATHWAY | mmu04670:Leukocyte transendothelial migration | 47 | 5.6 | 2.2e-15 | 1.2e-14 | |
KEGG_PATHWAY | mmu04068:FoxO signaling pathway | 50 | 6.0 | 5.7e-15 | 3.2e-14 | |
KEGG_PATHWAY | mmu04520:Adherens junction | 33 | 4.0 | 1.9e-14 | 1.1e-13 | |
KEGG_PATHWAY | mmu05231:Choline metabolism in cancer | 38 | 4.6 | 5.4e-14 | 3.0e-13 | |
KEGG_PATHWAY | mmu04621:NOD-like receptor signaling pathway | 29 | 3.5 | 6.0e-14 | 3.2e-13 | |
KEGG_PATHWAY | mmu05222:Small cell lung cancer | 37 | 4.4 | 7.5e-14 | 3.9e-13 | |
KEGG_PATHWAY | mmu05223:Non-small cell lung cancer | 30 | 3.6 | 1.1e-13 | 5.8e-13 | |
KEGG_PATHWAY | mmu04151:PI3K-Akt signaling pathway | 81 | 9.7 | 8.4e-13 | 4.2e-12 | |
KEGG_PATHWAY | mmu04915:Estrogen signaling pathway | 38 | 4.6 | 1.0e-12 | 4.9e-12 | |
KEGG_PATHWAY | mmu05152:Tuberculosis | 51 | 6.1 | 2.3e-12 | 1.1e-11 | |
KEGG_PATHWAY | mmu04919:Thyroid hormone signaling pathway | 40 | 4.8 | 2.6e-12 | 1.2e-11 | |
KEGG_PATHWAY | mmu04062:Chemokine signaling pathway | 54 | 6.5 | 2.7e-12 | 1.2e-11 | |
KEGG_PATHWAY | mmu04015:Rap1 signaling pathway | 57 | 6.8 | 1.1e-11 | 5.0e-11 | |
KEGG_PATHWAY | mmu04666:Fc gamma R-mediated phagocytosis | 34 | 4.1 | 1.8e-11 | 7.7e-11 | |
KEGG_PATHWAY | mmu05206:MicroRNAs in cancer | 44 | 5.3 | 2.0e-11 | 8.4e-11 | |
KEGG_PATHWAY | mmu04622:RIG-I-like receptor signaling pathway | 29 | 3.5 | 2.1e-11 | 8.7e-11 | |
KEGG_PATHWAY | mmu04611:Platelet activation | 41 | 4.9 | 3.6e-11 | 1.5e-10 | |
KEGG_PATHWAY | mmu04910:Insulin signaling pathway | 44 | 5.3 | 5.2e-11 | 2.1e-10 | |
KEGG_PATHWAY | mmu04150:mTOR signaling pathway | 27 | 3.2 | 6.3e-11 | 2.5e-10 | |
KEGG_PATHWAY | mmu05132:Salmonella infection | 32 | 3.8 | 9.2e-11 | 3.6e-10 | |
KEGG_PATHWAY | mmu04066:HIF-1 signaling pathway | 36 | 4.3 | 2.1e-10 | 8.3e-10 | |
KEGG_PATHWAY | mmu04810:Regulation of actin cytoskeleton | 54 | 6.5 | 1.1e-9 | 4.1e-9 | |
KEGG_PATHWAY | mmu04014:Ras signaling pathway | 55 | 6.6 | 1.4e-9 | 5.0e-9 | |
KEGG_PATHWAY | mmu05014:Amyotrophic lateral sclerosis (ALS) | 24 | 2.9 | 1.4e-9 | 5.0e-9 | |
KEGG_PATHWAY | mmu05211:Renal cell carcinoma | 26 | 3.1 | 2.0e-9 | 7.3e-9 | |
KEGG_PATHWAY | mmu04931:Insulin resistance | 35 | 4.2 | 2.8e-9 | 9.8e-9 | |
KEGG_PATHWAY | mmu04921:Oxytocin signaling pathway | 43 | 5.2 | 2.9e-9 | 1.0e-8 | |
KEGG_PATHWAY | mmu05134:Legionellosis | 24 | 2.9 | 3.9e-9 | 1.4e-8 | |
KEGG_PATHWAY | mmu04930:Type II diabetes mellitus | 22 | 2.6 | 7.2e-9 | 2.4e-8 | |
KEGG_PATHWAY | mmu05218:Melanoma | 27 | 3.2 | 8.5e-9 | 2.8e-8 | |
KEGG_PATHWAY | mmu05230:Central carbon metabolism in cancer | 25 | 3.0 | 1.2e-8 | 3.9e-8 | |
KEGG_PATHWAY | mmu04912:GnRH signaling pathway | 29 | 3.5 | 1.2e-8 | 4.0e-8 | |
KEGG_PATHWAY | mmu04550:Signaling pathways regulating pluripotency of stem cells | 40 | 4.8 | 1.4e-8 | 4.6e-8 | |
KEGG_PATHWAY | mmu04914:Progesterone-mediated oocyte maturation | 30 | 3.6 | 1.7e-8 | 5.3e-8 | |
KEGG_PATHWAY | mmu05100:Bacterial invasion of epithelial cells | 27 | 3.2 | 4.2e-8 | 1.3e-7 | |
KEGG_PATHWAY | mmu04024:cAMP signaling pathway | 45 | 5.4 | 2.1e-7 | 6.3e-7 | |
KEGG_PATHWAY | mmu04932:Non-alcoholic fatty liver disease (NAFLD) | 39 | 4.7 | 2.6e-7 | 7.9e-7 | |
KEGG_PATHWAY | mmu04144:Endocytosis | 53 | 6.4 | 5.0e-7 | 1.5e-6 | |
KEGG_PATHWAY | mmu04022:cGMP-PKG signaling pathway | 39 | 4.7 | 5.2e-7 | 1.5e-6 | |
KEGG_PATHWAY | mmu04750:Inflammatory mediator regulation of TRP channels | 30 | 3.6 | 9.4e-7 | 2.7e-6 | |
KEGG_PATHWAY | mmu05202:Transcriptional misregulation in cancer | 35 | 4.2 | 9.7e-7 | 2.8e-6 | |
KEGG_PATHWAY | mmu05219:Bladder cancer | 17 | 2.0 | 1.3e-6 | 3.8e-6 | |
KEGG_PATHWAY | mmu04350:TGF-beta signaling pathway | 27 | 3.2 | 1.6e-6 | 4.3e-6 | |
KEGG_PATHWAY | mmu04630:Jak-STAT signaling pathway | 35 | 4.2 | 2.4e-6 | 6.5e-6 | |
KEGG_PATHWAY | mmu05146:Amoebiasis | 28 | 3.4 | 5.0e-6 | 1.4e-5 | |
KEGG_PATHWAY | mmu04923:Regulation of lipolysis in adipocytes | 19 | 2.3 | 1.5e-5 | 4.1e-5 | |
KEGG_PATHWAY | mmu04390:Hippo signaling pathway | 36 | 4.3 | 1.7e-5 | 4.4e-5 | |
KEGG_PATHWAY | mmu04310:Wnt signaling pathway | 33 | 4.0 | 1.9e-5 | 5.0e-5 | |
KEGG_PATHWAY | mmu04141:Protein processing in endoplasmic reticulum | 37 | 4.4 | 2.6e-5 | 6.8e-5 | |
KEGG_PATHWAY | mmu05216:Thyroid cancer | 12 | 1.4 | 3.1e-5 | 8.0e-5 | |
KEGG_PATHWAY | mmu04920:Adipocytokine signaling pathway | 22 | 2.6 | 3.3e-5 | 8.3e-5 | |
KEGG_PATHWAY | mmu05416:Viral myocarditis | 17 | 2.0 | 3.6e-5 | 9.1e-5 | |
KEGG_PATHWAY | mmu04960:Aldosterone-regulated sodium reabsorption | 15 | 1.8 | 4.1e-5 | 0.0001 | |
KEGG_PATHWAY | mmu04360:Axon guidance | 30 | 3.6 | 5.5e-5 | 0.00013 | |
KEGG_PATHWAY | mmu05020:Prion diseases | 13 | 1.6 | 5.9e-5 | 0.00014 | |
KEGG_PATHWAY | mmu04720:Long-term potentiation | 19 | 2.3 | 7.2e-5 | 0.00017 | |
KEGG_PATHWAY | mmu04540:Gap junction | 22 | 2.6 | 0.00011 | 0.00027 | |
KEGG_PATHWAY | mmu05143:African trypanosomiasis | 12 | 1.4 | 0.00014 | 0.00032 | |
KEGG_PATHWAY | mmu04261:Adrenergic signaling in cardiomyocytes | 32 | 3.8 | 0.00014 | 0.00033 | |
KEGG_PATHWAY | mmu05321:Inflammatory bowel disease (IBD) | 16 | 1.9 | 0.00027 | 0.00063 | |
KEGG_PATHWAY | mmu04725:Cholinergic synapse | 25 | 3.0 | 0.00036 | 0.00083 | |
KEGG_PATHWAY | mmu04110:Cell cycle | 29 | 3.5 | 0.00039 | 0.00088 | |
KEGG_PATHWAY | mmu05031:Amphetamine addiction | 17 | 2.0 | 0.00039 | 0.00088 | |
KEGG_PATHWAY | mmu04114:Oocyte meiosis | 25 | 3.0 | 0.00052 | 0.0011 | |
KEGG_PATHWAY | mmu04728:Dopaminergic synapse | 28 | 3.4 | 0.00058 | 0.0013 | |
KEGG_PATHWAY | mmu04152:AMPK signaling pathway | 28 | 3.4 | 0.00058 | 0.0013 | |
KEGG_PATHWAY | mmu05030:Cocaine addiction | 14 | 1.7 | 0.00067 | 0.0015 | |
KEGG_PATHWAY | mmu04530:Tight junction | 28 | 3.4 | 0.00068 | 0.0014 | |
KEGG_PATHWAY | mmu04120:Ubiquitin mediated proteolysis | 28 | 3.4 | 0.00079 | 0.0017 | |
KEGG_PATHWAY | mmu04623:Cytosolic DNA-sensing pathway | 16 | 1.9 | 0.00079 | 0.0017 | |
KEGG_PATHWAY | mmu04115:p53 signaling pathway | 17 | 2.0 | 0.001 | 0.0021 | |
KEGG_PATHWAY | mmu04730:Long-term depression | 15 | 1.8 | 0.002 | 0.004 | |
KEGG_PATHWAY | mmu05010:Alzheimer's disease | 29 | 3.5 | 0.0069 | 0.014 | |
KEGG_PATHWAY | mmu04973:Carbohydrate digestion and absorption | 11 | 1.3 | 0.0074 | 0.015 | |
KEGG_PATHWAY | mmu05144:Malaria | 11 | 1.3 | 0.0093 | 0.019 | |
KEGG_PATHWAY | mmu05340:Primary immunodeficiency | 10 | 1.2 | 0.022 | 0.043 | |
KEGG_PATHWAY | mmu04070:Phosphatidylinositol signaling system | 15 | 1.8 | 0.023 | 0.045 | |
KEGG_PATHWAY | mmu05034:Alcoholism | 23 | 2.8 | 0.028 | 0.053 | |
KEGG_PATHWAY | mmu04270:Vascular smooth muscle contraction | 19 | 2.3 | 0.036 | 0.07 | |
KEGG_PATHWAY | mmu04320:Dorso-ventral axis formation | 7 | 0.8 | 0.037 | 0.071 | |
KEGG_PATHWAY | mmu05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 14 | 1.7 | 0.038 | 0.071 | |
KEGG_PATHWAY | mmu04612:Antigen processing and presentation | 11 | 1.3 | 0.04 | 0.074 | |
KEGG_PATHWAY | mmu03013:RNA transport | 22 | 2.6 | 0.048 | 0.089 | |
KEGG_PATHWAY | mmu05323:Rheumatoid arthritis | 13 | 1.6 | 0.061 | 0.11 | |
KEGG_PATHWAY | mmu04330:Notch signaling pathway | 10 | 1.2 | 0.068 | 0.12 | |
KEGG_PATHWAY | mmu05410:Hypertrophic cardiomyopathy (HCM) | 14 | 1.7 | 0.074 | 0.13 | |
KEGG_PATHWAY | mmu04916:Melanogenesis | 17 | 2.0 | 0.081 | 0.14 | |
KEGG_PATHWAY | mmu04723:Retrograde endocannabinoid signaling | 16 | 1.9 | 0.1 | 0.17 | |
KEGG_PATHWAY | mmu04922:Glucagon signaling pathway | 16 | 1.9 | 0.1 | 0.17 |